The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy

Intraductal carcinoma of the prostate (IDC-P) is recognized as a newly pathological entity in 2016 WHO classification. It's role in metastatic castration-resistant prostate cancer (CRPC) remains obscure. We aimed to explore the association of IDC-P with clinical outcome and to further identify...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Zhao, Jinge, Shen, Pengfei, Sun, Guangxi, Chen, Ni, Liu, Jiandong, Tang, Xin, Huang, Rui, Cai, Diming, Gong, Jing, Zhang, Xingming, Chen, Zhibin, Li, Xiang, Wei, Qiang, Zhang, Peng, Liu, Zhenhua, Liu, Jiyan, Zeng, Hao
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5589665/
https://ncbi.nlm.nih.gov/pubmed/28903426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19520
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados